Class 2 Device Recall ReEntry" Malecot Nephrostomy Catheter Set

• Date Initiated by Firm: December 12, 2017
• Create Date: March 18, 2018
• Recall Status: Terminated on October 24, 2019
• Recall Number: Z-1102-2018
• Recall Event ID: 79424
• Product Classification: Catheter, nephrostomy, general & plastic surgery - Product Code GBO
• Product: Re-Entry" Malecot Nephrostomy Catheter Set, Product Number: M0064101040, GTIN: 08714729008446; ; The Malecot Nephrostomy Catheter Set is intended to establish percutaneous nephrostomy drainage and is indicated for the following: Diagnostic Indications: " Antegrade pyelography " Pressure/perfusion study (Whitaker test) Therapeutic Indications: " Nephrostomy catheter drainage " Perfusion chemolysis of renal stones " Percutaneous nephrolithotomy " Percutaneous resection and coagulation of urothelial tumors
• Code Information: Expiration Date Range: 3/27/2018 9/25/2021; Batch: 16852983 18912864 20404111 16969146 18932466 20458384 16987703 19157072 20491745 17078511 19318043 20517724 17159358 19338399 20567074 17248134 19596298 20567075 17672818 19623064 20593962 17780452 19705478 20658862 17910342 19737920 20682997 17960225 19850692 20735792 17976830 19934631 20769252 18100917 20065714 20830243 18106456 20169834 20884298 18172896 20198263 20909294 18280357 20284828 21027051 18398908 20312727 21101918 18821698 20330766 21181528 18876334
• Recalling Firm/ Manufacturer: Boston Scientific Corporation; 100 Boston Scientific Way; Marlborough MA 01752-1234
• For Additional Information Contact: Donna M. Gardner; 508-683-4398
• Manufacturer Reason for Recall: Certain Malecot Nephrostomy Catheters are breaking at the mid-shaft bond during use.
• FDA Determined Cause: Under Investigation by firm
• Action: The firm, Boston Scientific, sent an "Urgent Medical Device Product Removal - Immediate Action Required" letter dated 12/12/2017 to its consignees. The letter described the product, problem and actions to be taken. The consignees were instructed to: identify and remove all affected batches from your inventory; immediately discontinue use of and segregate the affected product, and return it to Boston Scientific. Distributors were notified that this removal is to the customer level and asked to notify any customers who received affected product. Consignees were asked to complete and return the Replay Verification Tracking Form (even if you do not have any product to return) via email: BSCFieldActionCenter@bsci.com or Fax to: Field Action Center at 1-866-213-1806. If you have any questions, your local Sales Representative can answer any questions that you may have regarding this removal or contact Vice President , Regulatory Affairs at 508-683-4398 or email: Donna.Gardner@bsci.com or BSCFieldActionCenter@bsci.com.
• Quantity in Commerce: 2224
• Distribution: Worldwide Distribution: US (nationwide) in the following: AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KA, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, including the District of Columbia and Puerto Rico; and countries of: Argentina, Bolivia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Panama, Peru, Venezuela, Australia, Bangladesh, Botswana, China, Kuwait, Lebanon, Macau, Malaysia, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, and Zimbabwe.
• Total Product Life Cycle: TPLC Device Report

¹ A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
² Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
³ For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.